FDA approves quadrivalent flu vaccine for adults aged 65 and
The US Food and Drug Administration (FDA) has approved the first quadrivalent, adjuvanted influenza vaccine for use in adults ages 65 and older released by Seqirus, a world leader in Influenza Vaccines.

Fluad Quadrivalent uses the same MF59 adjuvant technology as found in the company’s Fluad trivalent vaccine to generate a broad immune response. The new quadrivalent vaccine includes an additional strain of Fluad, which the FDA approved in 2015..

The Centers for Disease Control and Prevention estimates that between 70% and 85% of seasonal influenza-related deaths occur in adults 65 years and older are at high risk for influenza-related complications each season and it is important to have influenza vaccines to help protect this vulnerable population.

Source : https://www.drugtopics.com/new-products/quadrivalent-flu-vaccine-approved-elders
J●y P●●●●r and 3 others like this2 shares
Like
Comment
Share